Eye drops are usually the first treatment for glaucoma, but your doctor may recommend laser treatment or surgery if drops are not controlling your eye pressure, if the disease is progressing despite medication, or if side effects make drops difficult to use long term. The decision is not a one-time event. It is an ongoing conversation between you and your eye care provider, based on how your eyes respond to treatment over time.
A glaucoma diagnosis can feel overwhelming, especially when your doctor starts discussing treatment options. Understanding the logic behind each decision can help you feel more in control of your care. Here is how eye doctors evaluate whether drops, laser, or surgery is the right step at each stage.
Why Lowering Eye Pressure Is the Goal
Glaucoma damages the optic nerve, which carries visual information from your eye to your brain. In most forms of glaucoma, elevated intraocular pressure (IOP) is the primary risk factor driving that damage.
The only proven way to slow or stop glaucoma progression is to lower IOP. According to the National Eye Institute, every treatment option for glaucoma, whether drops, laser, or surgery, is designed to reduce the pressure inside the eye to a level that protects the optic nerve.
Your doctor will set a “target pressure” for your eyes based on several factors: how advanced the damage is, what your baseline pressure was before treatment, your age, and how quickly the disease appears to be progressing. That target becomes the benchmark for evaluating whether your current treatment is working.
Step 1: Prescription Eye Drops
For most newly diagnosed patients, prescription eye drops are the first line of treatment. These medications lower IOP by either reducing the amount of fluid (aqueous humor) the eye produces or improving the rate at which fluid drains out.
The most commonly prescribed first-line drops are prostaglandin analogs, which work by increasing the outflow of fluid through a secondary drainage pathway. A review published in the journal BMC Ophthalmology confirms that prostaglandin analogs remain the cornerstone of medical therapy for open-angle glaucoma.
Other classes of eye drops include:
- Beta-blockers: Reduce fluid production inside the eye
- Alpha-adrenergic agonists: Both reduce production and increase outflow
- Carbonic anhydrase inhibitors: Slow fluid production
- Rho kinase inhibitors: Improve drainage through the trabecular meshwork
Your doctor may prescribe a single drop or a combination, depending on how much pressure reduction you need. Some patients respond well to one medication alone. Others require two or three different drops used at different times of day.
When Eye Drops Work Well
Drops are effective for many patients and can control glaucoma for years or even decades. They work well when:
- Your IOP reaches the target level consistently
- Follow-up exams show stable optic nerve health and visual fields
- You tolerate the medication without significant side effects
- You can maintain a consistent daily schedule
If your glaucoma is stable on drops and you are comfortable using them, there is no automatic reason to escalate to laser or surgery. Your doctor will continue monitoring with regular comprehensive eye exams to confirm that the disease is not progressing.
When Eye Drops Fall Short
Eye drops sound simple, but long-term compliance is harder than most patients expect. Research consistently shows that adherence to glaucoma drop regimens declines significantly over time. Common reasons include:
- Forgetting doses: Glaucoma has no symptoms in early and moderate stages, so patients do not feel the consequences of a missed dose
- Side effects: Redness, stinging, blurred vision, darkening of the eyelids or iris, and eyelash growth are common with prostaglandin analogs. Beta-blockers can lower heart rate and blood pressure or worsen asthma.
- Cost: Some newer glaucoma drops are expensive, even with insurance
- Difficulty with application: Older patients, patients with arthritis, or patients with tremors may struggle to instill drops accurately
- Ocular surface disease: Preservatives in many glaucoma drops can cause or worsen dry eye over time, creating a separate problem
If your IOP is not reaching the target despite using drops as prescribed, or if side effects are affecting your quality of life, your doctor will consider the next step.
Step 2: Laser Treatment (SLT)
Selective laser trabeculoplasty (SLT) has become a major part of modern glaucoma management. It is a quick, in-office procedure that uses low-energy laser pulses to stimulate the eye’s natural drainage system (the trabecular meshwork) to filter fluid more efficiently.
The landmark LiGHT trial, published in The Lancet, found that SLT was both safe and effective as a first-line treatment for open-angle glaucoma and ocular hypertension. Patients who received SLT as their initial treatment spent less on care and had better outcomes than those who started with eye drops alone.
Key points about SLT:
- The procedure takes about 5 to 10 minutes and is performed in your eye doctor’s office
- It is not painful. You may feel a slight sensation during the laser pulses, but numbing drops keep you comfortable
- Results develop over several weeks as the drainage system responds to the treatment
- IOP reduction typically ranges from 18 to 27%, according to a review in BMC Ophthalmology
- SLT can be repeated if the effect diminishes over time, unlike older laser treatments
- It may reduce or eliminate the need for daily eye drops
When Your Doctor May Recommend SLT
SLT may be recommended in several scenarios:
- As a first-line treatment instead of drops, especially for patients who may have difficulty with long-term drop compliance
- When drops are not lowering IOP enough on their own
- When drop side effects are affecting quality of life or causing ocular surface problems
- As an addition to drop therapy when a second medication would be needed
The American Academy of Ophthalmology and the European Glaucoma Society both recognize SLT as an appropriate first-line treatment option for open-angle glaucoma.
Step 3: Minimally Invasive Glaucoma Surgery (MIGS)
If drops and laser treatment are not achieving the target IOP, or if the disease is progressing despite those interventions, your doctor may recommend a minimally invasive glaucoma surgery (MIGS) procedure.
MIGS devices and techniques create new drainage pathways or improve existing ones to lower eye pressure. They are called “minimally invasive” because they involve smaller incisions, faster recovery, and fewer complications than traditional glaucoma surgeries.
MIGS procedures are often performed during cataract surgery, making them a convenient option for patients who need both procedures. However, they can also be done as standalone treatments.
Common MIGS approaches include:
- Trabecular bypass devices that create a direct channel through the drainage tissue
- Subconjunctival drainage devices that route fluid to a space beneath the outer membrane of the eye
- Canal-based procedures that open or expand the eye’s natural drainage canal
MIGS procedures typically lower IOP less dramatically than traditional surgeries, which makes them better suited for mild to moderate glaucoma. For advanced disease requiring very low target pressures, more aggressive surgical options may be needed.
Step 4: Traditional Glaucoma Surgery
For patients with advanced glaucoma or cases where less invasive treatments have not achieved adequate pressure control, traditional surgical procedures remain an important option.
Trabeculectomy
This is the most established glaucoma surgery. The surgeon creates a small opening in the wall of the eye, covered by a flap of tissue, that allows excess fluid to drain into a space called a “bleb” beneath the conjunctiva. The fluid is then absorbed by surrounding tissue.
According to the National Eye Institute, trabeculectomy successfully lowers eye pressure in approximately 7 out of 10 patients. It can achieve very low target pressures that drops and MIGS cannot always reach.
Recovery takes longer than MIGS, and the procedure requires careful follow-up to monitor the bleb and adjust healing. Your doctor may use anti-scarring medications during surgery to prevent the drainage site from closing prematurely.
Tube Shunt (Glaucoma Drainage Implant)
A tube shunt involves placing a small silicone tube in the eye that routes fluid to a reservoir plate attached to the outside of the eyeball. The fluid collects in the reservoir and is gradually absorbed.
Tube shunts are typically reserved for patients who have had a failed trabeculectomy, those with certain types of secondary glaucoma, or those with significant scarring from previous eye surgery.
How Your Doctor Weighs the Decision
Your eye doctor does not follow a rigid checklist. The treatment plan is individualized based on multiple factors evaluated at every visit.
Factors that influence the decision include:
- Your current IOP relative to the target: If pressure is consistently above the goal, the current treatment needs adjustment
- Rate of disease progression: Faster progression may push your doctor toward earlier surgical intervention, even if IOP is close to target
- Severity of existing damage: Advanced visual field loss leaves less margin for error, so tighter pressure control becomes critical
- Your age and life expectancy: Younger patients face more years of potential progression, which may favor more aggressive early treatment
- Tolerance of current treatment: If drops are causing significant side effects or compliance is inconsistent, switching to SLT or MIGS can improve both comfort and outcomes
- Other eye conditions: If you also need cataract surgery, combining it with a MIGS procedure can address both problems in one operation
- Your preferences and lifestyle: Your input matters. Some patients prefer the convenience of a procedure over decades of daily drops
The treatment ladder is not always strictly linear. Some eye doctors now offer SLT as a first-line option instead of drops, based on strong evidence from the LiGHT trial. Others may recommend MIGS combined with cataract surgery as an early intervention. Your doctor will explain the reasoning behind each recommendation.
What You Can Do as a Patient
Glaucoma management is a partnership. While your doctor guides the medical decisions, there are several things you can do to protect your vision.
- Keep every follow-up appointment. Glaucoma monitoring requires consistent pressure checks, optic nerve imaging, and visual field testing. Skipping appointments can allow undetected progression.
- Use your drops exactly as prescribed. If you struggle with the schedule, tell your doctor. There may be a simpler regimen or an alternative treatment.
- Report side effects honestly. Your doctor would rather adjust your treatment than have you quietly stop using a medication.
- Ask questions. Understanding why your doctor chose a specific treatment helps you stay engaged in your care.
The glaucoma specialists at Midwest Eye Professionals use advanced diagnostics to monitor disease progression and tailor treatment plans to each patient’s needs. Early detection and consistent management are the strongest tools for preserving your vision.
Frequently Asked Questions About Glaucoma Treatment
Can glaucoma be cured?
Glaucoma cannot be cured, and vision lost to optic nerve damage cannot be restored. However, treatment can slow or stop further progression in most patients. The goal is to lower eye pressure to a level that protects the remaining nerve fibers. With consistent monitoring and appropriate treatment, most glaucoma patients maintain functional vision throughout their lives.
Do I need to use eye drops forever?
Not necessarily. If SLT or surgery successfully lowers your IOP to the target range, your doctor may reduce or eliminate your drop regimen. Some patients who undergo SLT as a first-line treatment never need drops at all. However, glaucoma requires lifelong monitoring regardless of which treatment you use.
Is SLT better than eye drops?
The LiGHT trial showed that SLT was at least as effective as eye drops for first-line treatment and was associated with lower overall treatment costs. SLT eliminates the compliance challenge of daily drops. However, it does not work for every patient, and some people still need drops after laser treatment. Your doctor can help you weigh the options.
How long does SLT last?
The pressure-lowering effect of SLT typically lasts 1 to 5 years, depending on the individual. When the effect begins to wear off, the procedure can be repeated. This repeatability is one of the advantages of SLT over older laser treatments.
Is glaucoma surgery safe?
All surgical procedures carry some risk. MIGS procedures have a favorable safety profile with relatively few complications. Traditional surgeries like trabeculectomy and tube shunts are more invasive and carry higher risks, including infection, low eye pressure, and scarring. However, for patients with advanced glaucoma, the risk of untreated disease progression typically outweighs the surgical risks.
Will I go blind from glaucoma?
With early detection and consistent treatment, most glaucoma patients do not go blind. The risk of severe vision loss is highest in patients who are diagnosed late or who do not adhere to their treatment plan. Regular eye exams are the best defense, because glaucoma causes no symptoms until significant damage has already occurred.
Can glaucoma treatment be combined with cataract surgery?
Yes. MIGS procedures are frequently performed at the same time as cataract surgery. Combining the two procedures reduces the number of surgeries you need and can lower your IOP while improving your vision in a single operation. Your surgeon can evaluate whether you are a candidate for this combined approach.
This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your eye care provider for guidance specific to your health and vision. The team at Midwest Eye Professionals is available to answer your questions about glaucoma diagnosis and treatment planning.
